Literature DB >> 10755680

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups.

K T Mueser1, P R Yarnold, S D Rosenberg, C Swett, K M Miles, D Hill.   

Abstract

The prevalence and demographic and clinical correlates of lifetime substance use disorders were examined in a cohort of 325 recently hospitalized psychiatric patients (53% schizophrenia or schizoaffective disorder). Alcohol use was the most common type of substance use disorder, followed by cannabis and cocaine use. Univariate analyses indicated that gender (male), age (younger), education (less), history of time in jail, conduct disorder symptoms, and antisocial personality disorder symptoms were predictive of substance use disorders. Lifetime cannabis use disorder was uniquely predicted by marital status (never married) and fewer psychiatric hospitalizations during the previous 6 months. Optimal classification tree analysis, an exploratory, nonlinear method of identifying patient subgroups, was successful in predicting 74 percent to 86 percent of the alcohol, cannabis, and cocaine use disorders. The implications of this method for identifying specific patient subgroups and service needs are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10755680     DOI: 10.1093/oxfordjournals.schbul.a033438

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  34 in total

1.  Effective and Neurobiologically Sound.

Authors:  Andreas Heinz; Tomislav Majić
Journal:  Dtsch Arztebl Int       Date:  2015-10-09       Impact factor: 5.594

Review 2.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 3.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Authors:  Alan I Green
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

4.  Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.

Authors:  Yasemin Tekin Uludağ; Gülcan Güleç
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

5.  The Effectiveness of Supported Employment in People With Dual Disorders.

Authors:  Kim T Mueser; Kikuko Campbell; Robert E Drake
Journal:  J Dual Diagn       Date:  2011-05-11

6.  Predictors of referral to Supported Employment among consumers with co-occurring mental and substance use disorders.

Authors:  David E Biegel; David Beimers; Lauren D Stevenson; Robert J Ronis; Patrick Boyle
Journal:  Community Ment Health J       Date:  2009-09-19

7.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

8.  Assertive community treatment and associations with substance abuse problems.

Authors:  Maaike D van Vugt; Hans Kroon; Philippe A E G Delespaul; Cornelis L Mulder
Journal:  Community Ment Health J       Date:  2013-06-15

Review 9.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

10.  Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial.

Authors:  Kim T Mueser; Shirley M Glynn; Corinne Cather; Roberto Zarate; Lindy Fox; James Feldman; Rosemarie Wolfe; Robin E Clark
Journal:  Addict Behav       Date:  2009-04-01       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.